Fiscal Note

HB0258 - Medicaid Drug Utilization Amendments

State Impact:
Enactment of this legislation will require an appropriation of $23,000 from the General Fund and $56,000 in Federal Funds for FY 2009. In FY 2010, the costs of this legislation will be $25,300 from the General Fund and $61,900 in Federal Funds.

Funding SourceFY 2008
Approp.		FY 2009
Approp.		FY 2010
Approp.		FY 2008
Revenue		FY 2009
Revenue		FY 2010
Revenue
General Fund$0$25,300$25,300$0$0$0
General Fund, One-Time$0($2,300)$0$0$0$0
Federal Funds$0$56,000$61,900$0$0$0
   Total
$0
$79,000
$87,200
$0
$0
$0

Individual, Business and/or Local Impact:
The increased costs to the state and the amounts currently paid for generic immunosuppressive drugs affected by this legislation would now be paid to brand name manufacturers instead of generic drug manufacturers. Enactment of this bill likely will not result in direct, measurable costs and/or benefits for individuals or local governments.

1/29/2008, 4:16:46 PM, Lead Analyst: Frandsen, R.Office of the Legislative Fiscal Analyst